 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 06/01/2023 |
$0.34 |
$0.34 |
$0.32 |
$0.32 |
131.30K | | 06/02/2023 |
$0.33 |
$0.34 |
$0.32 |
$0.34 |
193.80K | | 06/05/2023 |
$0.35 |
$0.36 |
$0.34 |
$0.34 |
142.20K | | 06/06/2023 |
$0.36 |
$0.37 |
$0.33 |
$0.33 |
223.00K | | 06/07/2023 |
$0.34 |
$0.37 |
$0.34 |
$0.36 |
195.80K |
|
|
| Zynerba Pharmaceuticals is engaged in pharmaceutically-produced transdermal cannabinoid therapies for neuropsychiatric disorders. Co. is focused on improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome (FXS), autism spectrum disorder (ASD), and 22q11.2 deletion syndrome (22q). Co. is developing Zygel, the pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol. Zygel is being developed as a clear gel with once- or twice-daily dosing and is targeting treatment of behavioral symptoms of FXS, ASD and 22q. | |
|
Zynerba Pharmaceuticals (ZYNE) has the following price history information. Looking back at ZYNE historical stock prices for the last five trading days, on June 01, 2023, ZYNE opened at $0.34, traded as high as $0.34 and as low as $0.32, and closed at $0.32. Trading volume was a total of 131.30K shares. On June 02, 2023, ZYNE opened at $0.33, traded as high as $0.34 and as low as $0.32, and closed at $0.34. Trading volume was a total of 193.80K shares. On June 05, 2023, ZYNE opened at $0.35, traded as high as $0.36 and as low as $0.34, and closed at $0.34. Trading volume was a total of 142.20K shares. On June 06, 2023, ZYNE opened at $0.36, traded as high as $0.37 and as low as $0.33, and closed at $0.33. Trading volume was a total of 223.00K shares. On June 07, 2023, ZYNE opened at $0.34, traded as high as $0.37 and as low as $0.34, and closed at $0.36. Trading volume was a total of 195.80K shares.
ZYNE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Zynerba Pharmaceuticals shares, starting with a $10,000 purchase of ZYNE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
08/06/2015 |
|
| End date: |
06/07/2023 |
|
| Start price/share: |
$19.32 |
|
| End price/share: |
$0.36 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-98.14% |
|
| Average Annual Total Return: |
-39.83% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$186.25 |
|
| Years: |
7.84 |
|
|
|
| Date |
Close |
| 06/01/2023 | $0.32 | | 06/02/2023 | $0.34 | | 06/05/2023 | $0.34 | | 06/06/2023 | $0.33 | | 06/07/2023 | $0.36 |
|
|
Free ZYNE Email Alerts:
